SUBSCRIBE
SUBSCRIBE

Juno Therapeutics

NEWS
Juno Therapeutics was acquired by Bristol-Myers Squibb in 2019.
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
A Look at the Deaths That Plagued Juno and Kite Pharma’s CAR-T Trials
June 27, 2017
 · 
3 min read
Down but Not Out, Juno Fights Back with Positive CAR-T Results in its JCAR017 Program
Drug Development
Down but Not Out, Juno Fights Back with Positive CAR-T Results in its JCAR017 Program
June 5, 2017
 · 
2 min read
Juno Taps Ex-Genentech Scientist to Head Up R&D at New Bay Area Office
Business
Juno Taps Ex-Genentech Scientist to Head Up R&D at New Bay Area Office
April 17, 2017
 · 
2 min read
Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases
Deals
Celgene Stocks Up on More Juno Stock After Failed Flagship Drug Trial
March 29, 2017
 · 
3 min read
Down but Not Out, Juno Fights Back with Positive CAR-T Results in its JCAR017 Program
Business
Juno Finally Drops Problem CAR-T Drug That Caused Deaths
March 2, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Business
With Ex-Juno Employees on Its Roster, Seattle’s Silverback Therapeutics Files $10 Million Out of $60 Million Goal
February 15, 2017
 · 
2 min read
Down but Not Out, Juno Fights Back with Positive CAR-T Results in its JCAR017 Program
Deals
Social Media Rumors of Juno Acquisition Cause Stock Jitters
January 25, 2017
 · 
3 min read
BioForest
A Look at Whether Juno Can Recover After Losing More Than Half Its Value in 2016
January 16, 2017
 · 
1 min read
Kite Pharma's CAR-T Blood Cancer Candidate Succeeds in Major Study
Business
As Rival Juno Falters, Kite Pharma Touts New CAR-T Data and Maps Out BLA Submission Plans
December 5, 2016
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2015
JOBS
IN THE PRESS
Drug Development
ASCO2016: Juno Defined Composition CD19 Product Candidates Demonstrate Encouraging Clinical Outcomes And Tolerability
June 6, 2016
 · 
8 min read
Drug Development
ASCO2016: Juno’s Investigational CAR T Cell Product Candidate JCAR015 Shows High Response Rates In Adults With B-Cell ALL
June 6, 2016
 · 
7 min read
BioForest
Juno To Present At June 2016 Investor Conferences
June 1, 2016
 · 
1 min read
Business
Seattle Children’s And Juno Accelerate T-Cell Immunotherapy Clinical Trials For Children And Adults With Deadly Brain Cancers
May 26, 2016
 · 
5 min read
BioForest
Juno To Highlight Advancing Immuno-Oncology Portfolio At The 2016 ASCO Annual Meeting
May 19, 2016
 · 
1 min read
Business
Juno Reports First Quarter 2016 Financial Results
May 10, 2016
 · 
1 min read
BioForest
Juno To Present At The Bank of America Merrill Lynch 2016 Health Care Conference
May 4, 2016
 · 
1 min read
Business
Juno To Report First Quarter 2016 Financial Results On Monday, May 9
May 3, 2016
 · 
1 min read
Drug Development
Juno Unveils Promising Early Data on Two CAR T Cell Product Candidates
April 21, 2016
 · 
8 min read
Drug Development
Juno Announces Data Presentations At The AACR Annual Meeting
April 14, 2016
 · 
1 min read
Load More